INKT
MiNK Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.85 / 10
Netural
Analyst coverage is limited to one Strong Buy recommendation, yet its historical win rate is 0% with a –30.29% average return, reflecting poor track record. Fund‑flow scoring is 7.71 (good), showing overall inflow (~48%) but negative trends for block, medium, large investors, while small investors are positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-15
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate0.0%
Is money flowing into or out of INKT?
- INKT holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.85/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
